Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Obesity × mirabegron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Renal Insufficiency 1 Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Metformin 2 rosiglitazone-metformin combination 1 mirabegron 1 exemestane 1 atezolizumab 1 Tirzepatide 1 TIC10 compound 1 Rosiglitazone 1 Hydroquinones 1 Fish Oils 1 Docosahexaenoic Acids 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03049462 2026-03-11

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡